BIOMAT Database Logo BIOMAT Database Logo

[Lymphoblastic transformation in chronic myeloid leukemia]. 1976

G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
[Acute lymphoblastic transformation of chronic myeloid leukemia].
January 1983, La Tunisie medicale,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
T-lymphoblastic transformation of chronic myeloid leukemia.
February 2021, EJHaem,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
Lymphoblastic crisis in chronic myeloid leukemia.
June 1983, The Journal of the Association of Physicians of India,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
June 1997, Experimental hematology,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
[Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
December 1999, Sangre,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
[Acute lymphoblastic transformation in chronic myelogenous leukemia].
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
Isolated lymph node T lymphoblastic transformation of chronic myeloid leukemia during interferon treatment.
December 1999, American journal of hematology,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
Lymphoid blastic transformation in chronic myeloid leukemia.
May 1994, American journal of hematology,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
Autografting for chronic myeloid leukemia in transformation.
January 1985, American journal of hematology,
G Hoerni-Simon, and M Durand, and H Eghbali, and B Hoerni
Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation-an uncommon presentation in adults.
February 2014, Current oncology (Toronto, Ont.),
Copied contents to your clipboard!